跳转至内容
Merck
CN

G8887

Sigma-Aldrich

葡萄糖激酶 来源于嗜热脂肪芽胞杆菌

lyophilized powder, ≥250 units/mg protein

别名:

ATP:D-葡萄糖-6-磷酸转移酶

登录查看公司和协议定价


About This Item

CAS号:
MDL编号:
UNSPSC代码:
12352204

生物来源

Bacillus sp. (B. stearothermophilus)

质量水平

表单

lyophilized powder

比活

≥250 units/mg protein

组成

Protein, ≥60% biuret

运输

dry ice

储存温度

−20°C

正在寻找类似产品? 访问 产品对比指南

单位定义

在pH 9.0、30 °C条件下,一个单位每分钟可将1.0 μM D-葡萄糖磷酸化为6-磷酸D-葡萄糖。

外形

含 Tris 缓冲盐的冻干粉

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

常规特殊物品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834.
Edoardo Tartaglia et al.
Diabetes care, 36(1), e14-e14 (2012-12-25)
Response to Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834.
Ali J Chakera et al.
Diabetes care, 36(1), e15-e15 (2012-12-25)
Päivi J Miettinen et al.
Duodecim; laaketieteellinen aikakauskirja, 128(19), 1989-1998 (2012-11-20)
MODY (Maturity-Onset Diabetes of the Young) is a group of monogenic disorders characterized by autosomally dominantly inherited diabetes or hyperglycemia typically detected during adolescence or young adulthood. Usually there is at least one person in the family having developed the
Matthew D Blankschien et al.
ACS nano, 7(1), 654-663 (2012-12-15)
The use of plasmonic nanoparticle complexes for biomedical applications such as imaging, gene therapy, and cancer treatment is a rapidly emerging field expected to significantly improve conventional medical practices. In contrast, the use of these types of nanoparticles to noninvasively
David Callejas et al.
Diabetes, 62(5), 1718-1729 (2013-02-05)
Diabetes is associated with severe secondary complications, largely caused by poor glycemic control. Treatment with exogenous insulin fails to prevent these complications completely, leading to significant morbidity and mortality. We previously demonstrated that it is possible to generate a "glucose

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门